Published in Med Mol Morphol on December 21, 2007
Genomic indicators in the blood predict drug-induced liver injury. Pharmacogenomics J (2010) 1.09
CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation. J Autoimmun (2010) 1.03
Hepatoprotective effects of baicalein against CCl₄-induced acute liver injury in mice. World J Gastroenterol (2012) 0.85
Oroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury mice. PLoS One (2013) 0.84
Three-dimensional imaging of hepatic sinusoids in mice using synchrotron radiation micro-computed tomography. PLoS One (2013) 0.79
The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation. PLoS One (2012) 0.78
Tissue-Specific Regulation of p38α-Mediated Inflammation in Con A-Induced Acute Liver Damage. J Immunol (2015) 0.77
Liver regeneration. Science (1997) 12.80
Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol (2004) 6.36
Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology (2004) 3.09
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med (2003) 2.91
Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med (2002) 1.91
Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med (2001) 1.82
Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem (2001) 1.61
Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology (2003) 1.59
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53
The role of CXC chemokines as regulators of angiogenesis. Shock (1995) 1.52
Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol (1997) 1.40
Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol (2002) 1.36
Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest (1998) 1.28
Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology (2004) 1.25
CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J Immunol (2004) 1.16
Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin Exp Immunol (2001) 1.09
IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J Immunol (2001) 1.09
Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology (2006) 1.08
Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J Neurosci Res (2004) 0.97
Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol (2002) 0.97
Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling. Biochem Biophys Res Commun (2000) 0.95
Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepat (2001) 0.91
CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice. J Immunol (2005) 0.86
Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol (1999) 0.86
TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma. Cytokine (2000) 0.85
Recruitment of dendritic cells to pathological niches in inflamed liver. Med Mol Morphol (2005) 0.81
Acute liver failure: from bench to bedside. Transplant Proc (2005) 0.79
Serum IFN-inducible protein-10: a new clinical prognostic predictor of hepatocyte death in biliary atresia. J Pediatr Surg (1999) 0.79
Regulation of Th1 and Th2 immune responses by chemokines. Springer Semin Immunopathol (2000) 0.79
The carbon-tetrachloride-hepatotoxicity as a model of liver damage. First report: Long-time biochemical changes. Acta Hepatogastroenterol (Stuttg) (1975) 0.78
Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection. Am J Physiol Gastrointest Liver Physiol (2006) 0.77
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2015) 2.95
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation (2011) 2.94
Diagnostic value of peripheral fractional flow reserve in isolated iliac artery stenosis: a comparison with the post-exercise ankle-brachial index. J Endovasc Ther (2014) 2.63
Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med (2005) 2.23
Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care (2004) 2.06
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology (2003) 2.02
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging (2011) 1.99
Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb (2011) 1.97
Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg (2002) 1.91
Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med (2002) 1.91
Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology (2009) 1.89
Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation. J Cardiovasc Electrophysiol (2007) 1.88
Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol (2004) 1.85
CT colonography: false-negative interpretations. Radiology (2007) 1.84
Real-time in vivo virtual histology of colorectal lesions when using the endocytoscopy system. Gastrointest Endosc (2006) 1.84
On experiences of i2b2 (Informatics for integrating biology and the bedside) database with Japanese clinical patients' data. Bioinformation (2011) 1.82
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol (2002) 1.82
Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol (2003) 1.79
Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol (2012) 1.74
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin. J Hypertens (2003) 1.70
Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv (2013) 1.70
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest (2003) 1.68
Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract (2003) 1.64
Computer-aided diagnosis in thoracic CT. Semin Ultrasound CT MR (2005) 1.63
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol (2006) 1.60
Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. J Med Chem (2004) 1.58
Recurrence of hepatocellular carcinoma 102 months after successful eradication and removal of membranous obstruction of the inferior vena cava. J Gastroenterol (2004) 1.57
Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg (2003) 1.55
Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation (2013) 1.55
Impact of angiosome-oriented revascularization on clinical outcomes in critical limb ischemia patients without concurrent wound infection and diabetes. J Endovasc Ther (2014) 1.51
Propensity score analysis of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. J Endovasc Ther (2014) 1.49
Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia. Oncology (2011) 1.48
Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia. J Vasc Surg (2011) 1.48
Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study. Circ J (2014) 1.48
The association between use of mobile phones after lights out and sleep disturbances among Japanese adolescents: a nationwide cross-sectional survey. Sleep (2011) 1.47
Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol (2005) 1.47
Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils. Digestion (2007) 1.47
SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin. J Am Soc Nephrol (2004) 1.47
Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv (2011) 1.46
T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes. Diabetes Care (2002) 1.45
Valve repair improves central sleep apnea in heart failure patients with valvular heart diseases. Circ J (2009) 1.45
Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv (2011) 1.44
Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension (2007) 1.43
Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol (2006) 1.41
Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease. J Endovasc Ther (2014) 1.39
Beta-blocker Treatment Does Not Worsen Critical Limb Ischemia in Patients Receiving Endovascular Therapy. J Atheroscler Thromb (2014) 1.39
Three-dimensional digital subtraction angiography in evaluation of vertebro-basilar artery dissections: comparison with 2D DSA. J Neuroimaging (2009) 1.38
Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction. Int Heart J (2016) 1.38
Presence of diastolic dysfunction in patients with peripheral artery disease. Angiology (2013) 1.37
An epidemiologic study of self-reported sleep problems among Japanese adolescents. Sleep (2004) 1.36
Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol (2002) 1.36
Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol (2004) 1.36
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
Quantitative computerized analysis of diffuse lung disease in high-resolution computed tomography. Med Phys (2003) 1.32
Investigation of psychophysical measure for evaluation of similar images for mammographic masses: preliminary results. Med Phys (2005) 1.32
Inflammatory myofibroblastic tumor of the lung. Eur J Cardiothorac Surg (2004) 1.31
Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene. J Clin Neurosci (2008) 1.30
A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med Mol Morphol (2013) 1.30
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg (2005) 1.30
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg (2003) 1.29
Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol (2012) 1.27
Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A (2002) 1.26
Insomnia among Japanese adolescents: a nationwide representative survey. Sleep (2006) 1.26
Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg (2014) 1.25
Report of the 16th follow-up survey of primary liver cancer. Hepatol Res (2005) 1.25
Is limited resection appropriate for radiologically "solid" tumors in small lung cancers? Ann Thorac Surg (2012) 1.24
Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol (2003) 1.24
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Acad Radiol (2012) 1.21
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol (2003) 1.21
Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol (2006) 1.21
Clinicopathologic features of peripheral squamous cell carcinoma of the lung. Ann Thorac Surg (2004) 1.20
Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol (2012) 1.19
A run-based two-scan labeling algorithm. IEEE Trans Image Process (2008) 1.19
Malignant glomus tumor of the lung. Pathol Int (2003) 1.18
Left pneumonectomy for lung cancer after correction of contralateral partial anomalous pulmonary venous return. Ann Thorac Surg (2005) 1.18
A dual-stage method for lesion segmentation on digital mammograms. Med Phys (2007) 1.17
CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J Immunol (2004) 1.16
Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels (2010) 1.16
Radiologists' performance for differentiating benign from malignant lung nodules on high-resolution CT using computer-estimated likelihood of malignancy. AJR Am J Roentgenol (2004) 1.15
Rat nephrin modulates cell morphology via the adaptor protein Nck. Biochem Biophys Res Commun (2006) 1.15
Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int (2005) 1.15
Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients. Interact Cardiovasc Thorac Surg (2011) 1.14
Computer-aided diagnosis systems for lung cancer: challenges and methodologies. Int J Biomed Imaging (2013) 1.14
Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord (2011) 1.14
Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res (2008) 1.14
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol (2006) 1.12
The PLASTID DIVISION1 and 2 components of the chloroplast division machinery determine the rate of chloroplast division in land plant cell differentiation. Plant Cell (2009) 1.12
Complex anatomy surrounding the left atrial posterior wall: analysis with 3D computed tomography. Heart Vessels (2011) 1.12
Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg (2013) 1.12
Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis (2010) 1.11
Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol (2005) 1.11